Phenylephrine HCl Injection Recalled for Defective Container
Athenex Pharma Solutions is recalling Phenylephrine HCl Injection (20 mg, 250 mL excel bags) distributed nationwide due to defective container issues. The recall affects three specific lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a defective container (a manufacturing or packaging issue). The source text does not report any illnesses or injuries, and the hazard is a container defect rather than chemical contamination or a high-risk pathogen, meeting the criteria for a Moderate severity rating.
Plain-English summary
Athenex Pharma Solutions, LLC is recalling Phenylephrine HCl Injection in 0.9% Sodium Chloride, 20 mg, 250 mL excel bags, distributed nationwide in the United States. A total of 1,980 bags are affected by this recall.
The recall was initiated because of a defective container. The affected lots are: Lot #F2101654 (expiration 5/30/22), Lot #F2101834 (expiration 7/03/22), and Lot #F2200110 (expiration 7/27/22). The product is prescription-only.
This is a voluntary recall initiated by the firm. The recall was reported on March 30, 2022, and was terminated on August 4, 2022. Healthcare providers and patients who have received this product should contact Athenex Pharma Solutions, LLC or their healthcare provider for guidance.
The recalled product
- Product
- Phenylephrine HCl Injection in 0.9% Sodium Chloride, 20 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-491-15
- Manufacturer
- Athenex Pharma Solutions, LLC
- Hazard
- defective-container
- packaging-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: F2101654
- Exp 5/30/22
- F2101834
- Exp 7/03/22
- F2200110
- Exp 7/27/22
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27